搜索临床试验以:甲磺酸达拉非尼
总计1800个结果
-
University Hospital, BordeauxNovartis; Ministry of Health, France完全的
-
Maisonneuve-Rosemont HospitalHippocrate Research & Development未知
-
Memorial Sloan Kettering Cancer CenterNovartis; National Comprehensive Cancer Network完全的
-
National Cancer Institute (NCI)撤销
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLC完全的
-
Novartis Pharmaceuticals完全的
-
National Cancer Institute (NCI)完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Tianjin Chasesun Pharmaceutical Co., LTDSouthwest Hospital, China完全的
-
European Organisation for Research and Treatment...完全的
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
National Cancer Institute (NCI)招聘中胶质母细胞瘤 | 恶性胶质瘤 | 间变性星形细胞瘤 | 间变性星形细胞瘤,未另行说明 | 间变性神经节胶质瘤 | 间变性多形性黄色星形细胞瘤 | 世界卫生组织 3 级神经胶质瘤美国, 波多黎各
-
University of Texas Southwestern Medical Center招聘中
-
University of Milano Bicocca完全的
-
Novartis Pharmaceuticals完全的
-
European Organisation for Research and Treatment...完全的
-
Translational Research Center for Medical Innovation...Niigata University Medical & Dental Hospital完全的
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals完全的真性红细胞增多症 | 慢性粒单核细胞白血病 | 嗜酸性粒细胞增多综合征 | 慢性粒细胞白血病 | 肥大细胞增多症美国
-
Massachusetts General HospitalNovartis Pharmaceuticals完全的
-
European Organisation for Research and Treatment...Australasian Gastro-Intestinal Trials Group; Italian Sarcoma Group; Scandinavian Sarcoma Group未知胃肠道间质瘤
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Brigham and Women's Hospital完全的
-
Novartis Pharmaceuticals完全的
-
Poitiers University HospitalNovartis完全的
-
National Cancer Institute (NCI)主动,不招人转移性尿路上皮癌 | III 期膀胱尿路上皮癌 AJCC v6 和 v7 | IV 期膀胱尿路上皮癌 AJCC v7 | 局部晚期尿路上皮癌 | 复发性尿路上皮癌 | 不可切除的尿路上皮癌 | 晚期尿路上皮癌美国
-
Novartis Pharmaceuticals完全的
-
Duke UniversityNovartis Pharmaceuticals完全的
-
Eisai Inc.Merck Sharp & Dohme LLC完全的实体瘤美国, 中国, 比利时, 澳大利亚, 意大利, 大韩民国, 德国, 荷兰, 波兰, 罗马尼亚, 泰国
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals终止